← Open Payments lookup

JOSEPH FROEHNER: Open Payments

NPI 1811619307 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$601 in 30 payments from 11 companies in 2025. Trend: 2023 $155 · 2024 $106 · 2025 $601

Food & beverage: $601
CompanyPaymentsAmount
ABBVIE INC.10$187
Novo Nordisk Inc4$84
Lilly USA, LLC4$69
Janssen Pharmaceuticals, Inc2$48
HEARTFLOW, INC.1$47
Boehringer Ingelheim Pharmaceuticals, Inc.2$39
Otsuka America Pharmaceutical, Inc.2$38
AstraZeneca Pharmaceuticals LP2$30
Alnylam Pharmaceuticals Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18

Products named: VRAYLAR, Wegovy, SPRAVATO, FFRct, QULIPTA, REXULTI, MOUNJARO, JARDIANCE.

Industry payments across NE — which companies pay providers there.